ML239 is a selective inhibitor of breast cancer stem cells. It inhibits cancer stem cells with an IC₅₀ of 1.16 μM with 24-fold selec tivity against the control cell line. ML239 alters the expression of genes in the MAPK, NF-κB, and inflammatory cyto

Numero articolo: BIOV2696-5
Unità di misura: 5 MG
https://grogg-prod.braintec.cloud/web/image/product.template/923729/image_1920?unique=67c7460

133,00 CHF 133.0 CHF 133,00 CHF

133,00 CHF

Not Available For Sale

    Questa combinazione non esiste.

    Tempo di consegna attuale su richiesta

    Produttore: BIOVISION
    Numero del produttore: 2696-5
    Temperatura di stoccaggio: Freezer (-20)

    ML239 is a selective inhibitor of breast cancer stem cells. It inhibits cancer stem cells with an IC₅₀ of 1.16 μM with 24-fold selec tivity against the control cell line. ML239 alters the expression of genes in the MAPK, NF-κB, and inflammatory cyto